LSTA
LSTA
NASDAQ · Biotechnology

Lisata Therapeutics Inc

$1.21
-0.07 (-5.47%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Buy 6 67%
Hold 3 33%
Sell 0 0%
Price Target
Analyst Price Target +2,534.7% upside
Low Target $19.01
Average Target $31.88
High Target $45.37
Current Price $1.21
Current
$1.21
Target
$31.88
$19.01 $31.88 avg $45.37
Scenario Analysis
Bear Case
$19.01
1,471.1%
Low target
Base Case
$31.88
+2,534.7%
Avg target
Bull Case
$45.37
+3,649.6%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$5.07
-76.1% from high
52-Week Low
$0.96
+26.0% from low
Target vs 52W High
$31.88
+528.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.3%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.3%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -31.8%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -51.4%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -32.5%